Open Beta
MetriLume

US marketsBDSX

SEC-sourced researchBeta

BDSX

BIODESIX INC

Company comparison ↗

Data passport

CIK
0001439725
Exchange
Nasdaq
Business activity
— · SIC 8071
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 71,323,000.0000 USD; December 2025: 88,499,000.0000 USD88.5M USD0 USD0December 2024December 2025
BDSX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202471,323,000.0000Feb 26, 2026
December 202588,499,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202588,499,000.0000-35,265,000.0000-23,271,000.000087,476,000.000089,941,000.0000Feb 26, 2026
December 202471,323,000.0000-42,931,000.0000-48,649,000.000097,244,000.000076,368,000.0000Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$88.5MDecember 2025Feb 26, 202610-K
Previous period revenueRevenues$71.32MDecember 2024Feb 26, 202610-K
Net incomeNetIncomeLoss-$35.27MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$23.27MDecember 2025Feb 26, 202610-K
Total assetsAssets$87.48MDecember 2025Feb 26, 202610-K
Total liabilitiesLiabilities$89.94MDecember 2025Feb 26, 202610-K

New filings

Explore methodology ↗